LabCorp takes Qiagen nucleic acid robot:
This article was originally published in Clinica
Executive Summary
LabCorp is to use Qiagen's BioRobot 9604 and QIAamp 96 viral ribonucleic acid (RNA) kit as a standard package for high-throughput nucleic acid sample preparation. LabCorp will use the two products in its HIV resistance testing services. Qiagen, a Valencia, California-based subsidiary of the Dutch holding company Qiagen NV, says the combination automates the manual process of viral RNA purification. LabCorp carries out diagnostic tests for physicians, hospitals and clinics.
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.